Short-Course Oral Treatment Option Approved for Relapsing Forms of MS - Monthly Prescribing Reference https://t.co/MlafpInqMi
— IDRO (@IDROOhio) April 2, 2019
from Twitter https://twitter.com/IDROOhio
April 02, 2019 at 03:32AM
Tuesday, April 2, 2019
Short-Course Oral Treatment Option Approved for Relapsing Forms of MS - Monthly Prescribing Reference https://t.co/MlafpInqMi
from Twitter https://twitter.com/IDROOhio
April 02, 2019 at 03:32AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment